Department of Tissue Regeneration, MIRA Institute for Biomedical Engineering and Technical Medicine, PO Box 217, 7500AE Enschede, The Netherlands.
Lab Chip. 2013 Sep 21;13(18):3512-28. doi: 10.1039/c3lc50293g.
The aim of regenerative medicine is to restore or establish normal function of damaged tissues or organs. Tremendous efforts are placed into development of novel regenerative strategies, involving (stem) cells, soluble factors, biomaterials or combinations thereof, as a result of the growing need caused by continuous population aging. To satisfy this need, fast and reliable assessment of (biological) performance is sought, not only to select the potentially interesting candidates, but also to rule out poor ones at an early stage of development. Microfluidics may provide a new avenue to accelerate research and development in the field of regenerative medicine as it has proven its maturity for the realization of high-throughput screening platforms. In addition, microfluidic systems offer other advantages such as the possibility to create in vivo-like microenvironments. Besides the complexity of organs or tissues that need to be regenerated, regenerative medicine brings additional challenges of complex regeneration processes and strategies. The question therefore arises whether so much complexity can be integrated into microfluidic systems without compromising reliability and throughput of assays. With this review, we aim to investigate whether microfluidics can become widely applied in regenerative medicine research and/or strategies.
再生医学的目的是恢复或建立受损组织或器官的正常功能。由于人口老龄化的持续增长,人们对新型再生策略的需求不断增加,因此投入了大量的精力来开发涉及(干细胞)细胞、可溶性因子、生物材料或它们的组合的策略。为了满足这一需求,人们寻求快速、可靠的(生物)性能评估方法,不仅要选择有潜力的候选者,还要在开发的早期阶段排除效果不佳的候选者。微流控技术可能为再生医学领域的研究和开发提供新的途径,因为它已经证明了其在实现高通量筛选平台方面的成熟度。此外,微流控系统还具有其他优点,例如能够创造类似于体内的微环境。除了需要再生的器官或组织的复杂性之外,再生医学还带来了复杂的再生过程和策略的额外挑战。因此,人们不禁要问,如此多的复杂性是否可以在不影响检测可靠性和通量的情况下集成到微流控系统中。本文旨在探讨微流控技术是否可以广泛应用于再生医学研究和/或策略中。